Literature DB >> 24199708

Homeostatic defects in B cells deficient in the E3 ubiquitin ligase ARF-BP1 are restored by enhanced expression of MYC.

Chen-Feng Qi1, Ruihua Zhang, Jiafang Sun, Zhaoyang Li, Dong-Mi Shin, Hongsheng Wang, Alexander L Kovalchuk, Tomomi Sakai, Huabao Xiong, Ning Kon, Wei Gu, Herbert C Morse.   

Abstract

The E3 ligase ARF-BP1 governs the balance of life and death decisions by directing the degradation of p53 and enhancing the transcriptional activity of MYC. We find B cells selectively deficient in ARF-BP1 have many defects in developing and mature B cells associated with increased expression of p53 and reduced expression of Myc. Overexpression of Myc results in suppression of p53 and complete reversal of defects induced by ARF-BP1 deficiency. These findings indicate that the dynamic balance between MYC and p53 required for normal B cell maturation and function is finely tuned and critically dependent on the activities of ARF-BP1. Published by Elsevier Ltd.

Entities:  

Keywords:  ARF-BP1; B cell development; MYC; p53

Mesh:

Substances:

Year:  2013        PMID: 24199708      PMCID: PMC4077183          DOI: 10.1016/j.leukres.2013.09.009

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  20 in total

Review 1.  Maintaining appearances--the role of p53 in adult neurogenesis.

Authors:  Silvia Medrano; Heidi Scrable
Journal:  Biochem Biophys Res Commun       Date:  2005-06-10       Impact factor: 3.575

2.  Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis.

Authors:  Qing Zhong; Wenhua Gao; Fenghe Du; Xiaodong Wang
Journal:  Cell       Date:  2005-07-01       Impact factor: 41.582

3.  B lymphocyte-specific, Cre-mediated mutagenesis in mice.

Authors:  R C Rickert; J Roes; K Rajewsky
Journal:  Nucleic Acids Res       Date:  1997-03-15       Impact factor: 16.971

4.  c-Myc is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells.

Authors:  Zuqin Nie; Gangqing Hu; Gang Wei; Kairong Cui; Arito Yamane; Wolfgang Resch; Ruoning Wang; Douglas R Green; Lino Tessarollo; Rafael Casellas; Keji Zhao; David Levens
Journal:  Cell       Date:  2012-09-28       Impact factor: 41.582

5.  Transcriptional amplification in tumor cells with elevated c-Myc.

Authors:  Charles Y Lin; Jakob Lovén; Peter B Rahl; Ronald M Paranal; Christopher B Burge; James E Bradner; Tong Ihn Lee; Richard A Young
Journal:  Cell       Date:  2012-09-28       Impact factor: 41.582

6.  A VH12 transgenic mouse exhibits defects in pre-B cell development and is unable to make IgM+ B cells.

Authors:  H Wang; J Ye; L W Arnold; S K McCray; S H Clarke
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

7.  Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.

Authors:  Sung Sup Park; Joong Su Kim; Lino Tessarollo; James D Owens; Liangping Peng; Seong Su Han; Seung Tae Chung; Ted A Torrey; Wan C Cheung; Roberto D Polakiewicz; Nicole McNeil; Thomas Ried; J Frederic Mushinski; Herbert C Morse; Siegfried Janz
Journal:  Cancer Res       Date:  2005-02-15       Impact factor: 12.701

8.  ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor.

Authors:  Delin Chen; Ning Kon; Muyang Li; Wenzhu Zhang; Jun Qin; Wei Gu
Journal:  Cell       Date:  2005-07-01       Impact factor: 41.582

9.  B cell differentiation and isotype switching is related to division cycle number.

Authors:  P D Hodgkin; J H Lee; A B Lyons
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

10.  Characterization of ARF-BP1/HUWE1 interactions with CTCF, MYC, ARF and p53 in MYC-driven B cell neoplasms.

Authors:  Chen-Feng Qi; Yong-Soo Kim; Shao Xiang; Ziedulla Abdullaev; Ted A Torrey; Siegfried Janz; Alexander L Kovalchuk; Jiafang Sun; Delin Chen; William C Cho; Wei Gu; Herbert C Morse Iii
Journal:  Int J Mol Sci       Date:  2012-05-21       Impact factor: 6.208

View more
  4 in total

1.  HUWE1 interacts with PCNA to alleviate replication stress.

Authors:  Katherine N Choe; Claudia M Nicolae; Daniel Constantin; Yuka Imamura Kawasawa; Maria Rocio Delgado-Diaz; Subhajyoti De; Raimundo Freire; Veronique Aj Smits; George-Lucian Moldovan
Journal:  EMBO Rep       Date:  2016-05-04       Impact factor: 8.807

2.  The E3 ligase HUWE1 inhibition as a therapeutic strategy to target MYC in multiple myeloma.

Authors:  Lisa J Crawford; David C Campbell; Jonathan J Morgan; Michelle A Lawson; Jennifer M Down; Dharminder Chauhan; Roisin M McAvera; Treen C Morris; Claudia Hamilton; Aswini Krishnan; Krishnaraj Rajalingam; Andrew D Chantry; Alexandra E Irvine
Journal:  Oncogene       Date:  2020-06-10       Impact factor: 9.867

3.  Drosophila HUWE1 Ubiquitin Ligase Regulates Endoreplication and Antagonizes JNK Signaling During Salivary Gland Development.

Authors:  Yifat Yanku; Eliya Bitman-Lotan; Yaniv Zohar; Estee Kurant; Norman Zilke; Martin Eilers; Amir Orian
Journal:  Cells       Date:  2018-09-26       Impact factor: 6.600

Review 4.  The giant E3 ligase HUWE1 is linked to tumorigenesis, spermatogenesis, intellectual disability, and inflammatory diseases.

Authors:  Lu Qi; Xiaoqing Xu; Xiaopeng Qi
Journal:  Front Cell Infect Microbiol       Date:  2022-07-22       Impact factor: 6.073

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.